Lipella Pharmaceuticals Inc. Surges with Phase 2a Initiation
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) has been garnering attention recently. On Friday, the stock saw a modest 2.3% increase during regular trading hours. However, by early Monday premarket hours, the stock soared an additional 65%, moving from $0.39 to $0.69. This dramatic rise has sparked significant interest among investors, with many bullish on the stock […]
Lipella Pharmaceuticals Inc. Surges with Phase 2a Initiation Read More »